Results 171 to 180 of about 20,991 (215)
Some of the next articles are maybe not open access.
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
Journal of Vascular and Interventional Radiology, 2019Chronic thromboembolic pulmonary hypertension (CTEPH) is classified as Group-4 pulmonary hypertension caused by organized thrombi in pulmonary arteries. Pulmonary endarterectomy (PEA) has been shown to improve the symptoms and prognoses of patients with proximal CTEPH.
Sreeja, Sanampudi +2 more
+7 more sources
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
Cardiovascular Intervention and Therapeutics, 2021Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by chronic stenosis or obstruction of the pulmonary arteries due to thromboembolism. Although previous studies have shown untreated CTEPH has a poor prognosis, the establishment of gold-standard therapies including pulmonary endarterectomy, balloon pulmonary angioplasty (BPA), and medical ...
Kyoko, Hirakawa +9 more
openaire +2 more sources
Management of Complications of Balloon Pulmonary Angioplasty
Interventional Cardiology Clinics, 2023Since the publication of the first case series reporting the outcomes of patients with chronic thromboembolic pulmonary hypertension who underwent treatment with balloon pulmonary angioplasty more than 30 years ago, significant improvements to the procedural technique have made balloon pulmonary angioplasty (BPA) a safe and effective therapy that we ...
Amine, Nasri +2 more
openaire +2 more sources
Balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension
BMJ Case Reports, 2022Balloon pulmonary angioplasty (BPA) is an emerging treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or residual/recurrent pulmonary hypertension after pulmonary thromboendarterectomy. We report two patients with inoperable and severe CTEPH who were submitted to the BPA programme after optimised treatment with long-term ...
Pereira, Ana Rita +3 more
openaire +3 more sources
2017
Balloon pulmonary angioplasty (BPA) is a promising treatment option for patients with chronic thromboembolic pulmonary hypertension who are considered ineligible for surgical treatment. Since 2012, the effect of balloon pulmonary angioplasty has been reported mainly in Japan, but currently, it is attracting the attention of many pulmonary hypertension ...
Hiromi Matsubara, Aiko Ogawa
openaire +1 more source
Balloon pulmonary angioplasty (BPA) is a promising treatment option for patients with chronic thromboembolic pulmonary hypertension who are considered ineligible for surgical treatment. Since 2012, the effect of balloon pulmonary angioplasty has been reported mainly in Japan, but currently, it is attracting the attention of many pulmonary hypertension ...
Hiromi Matsubara, Aiko Ogawa
openaire +1 more source
Balloon Pulmonary Angioplasty in Patients With Thromboembolic Pulmonary Hypertension
Current Treatment Options in Cardiovascular Medicine, 2018Chronic thromboembolic pulmonary hypertension (CTEPH) is the only potentially curable form of precapillary pulmonary hypertension. Although pulmonary endarterectomy (PEA) is the preferred management strategy, a significant number of CTEPH patients will have an inoperable disease.
Panagiotis, Karyofyllis +3 more
openaire +2 more sources
Heart and Vessels, 2016
We experienced a rare complication where extravasation developed a pseudo-chamber long after the balloon pulmonary angioplasty for supravalvular pulmonary stenosis. A 3-month-old girl was diagnosed with an anomalous origin of the left coronary artery from the pulmonary artery. She underwent the Takeuchi procedure at 10 months of age.
Hisashi, Sugiyama +3 more
openaire +2 more sources
We experienced a rare complication where extravasation developed a pseudo-chamber long after the balloon pulmonary angioplasty for supravalvular pulmonary stenosis. A 3-month-old girl was diagnosed with an anomalous origin of the left coronary artery from the pulmonary artery. She underwent the Takeuchi procedure at 10 months of age.
Hisashi, Sugiyama +3 more
openaire +2 more sources
Balloon angioplasty for branch pulmonary artery stenosis—Cutting balloons
Catheterization and Cardiovascular Interventions, 2007AbstractPulmonary artery stenosis can cause right ventricular strain but intrapulmonary lesions are inaccessible to surgery; moreover, some are also resistant to high pressure balloon angioplasty. An alternative is the use of microsurgical devices mounted on balloons for transvenous delivery, including cutting balloons. The current literature is sparse
openaire +2 more sources
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
Current Opinion in Pulmonary Medicine, 2015Chronic thromboembolic pulmonary hypertension (CTEPH), especially when severe in patients unsuited for pulmonary endarterectomy, has a poor prognosis. Balloon pulmonary angioplasty (BPA) is a new catheter-based alternative treatment option for patients with inoperable CTEPH. BPA has not been widely accepted, however, primarily because of possible fatal
openaire +2 more sources